- Home
- ATHA vs VS Comparison
ATHA vs VS Comparison
Compare ATHA & VS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATHA
- VS
- Stock Information
- Founded
- ATHA 2011
- VS 2013
- Country
- ATHA United States
- VS United States
- Employees
- ATHA N/A
- VS N/A
- Industry
- ATHA Medicinal Chemicals and Botanical Products
- VS EDP Services
- Sector
- ATHA Health Care
- VS Technology
- Exchange
- ATHA Nasdaq
- VS Nasdaq
- Market Cap
- ATHA 10.6M
- VS 10.1M
- IPO Year
- ATHA 2020
- VS N/A
- Fundamental
- Price
- ATHA $0.42
- VS $2.59
- Analyst Decision
- ATHA Buy
- VS Hold
- Analyst Count
- ATHA 4
- VS 1
- Target Price
- ATHA $11.25
- VS $2.00
- AVG Volume (30 Days)
- ATHA 239.8K
- VS 55.7K
- Earning Date
- ATHA 07-31-2025
- VS 08-13-2025
- Dividend Yield
- ATHA N/A
- VS N/A
- EPS Growth
- ATHA N/A
- VS N/A
- EPS
- ATHA N/A
- VS N/A
- Revenue
- ATHA N/A
- VS $230,132.00
- Revenue This Year
- ATHA N/A
- VS $3,459.21
- Revenue Next Year
- ATHA N/A
- VS N/A
- P/E Ratio
- ATHA N/A
- VS N/A
- Revenue Growth
- ATHA N/A
- VS 64.71
- 52 Week Low
- ATHA $0.22
- VS $1.00
- 52 Week High
- ATHA $3.67
- VS $9.59
- Technical
- Relative Strength Index (RSI)
- ATHA 73.73
- VS 59.15
- Support Level
- ATHA $0.29
- VS $2.25
- Resistance Level
- ATHA $0.32
- VS $2.78
- Average True Range (ATR)
- ATHA 0.03
- VS 0.21
- MACD
- ATHA 0.01
- VS 0.03
- Stochastic Oscillator
- ATHA 78.16
- VS 77.91
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug candidate designed to enhance the activity of the neurotrophic hepatocyte growth factor (HGF) system; ATH-1020 a novel, orally available, next-generation small molecule drug candidate designed to positively modulate the neurotrophic HGF system; ATH-1105 is a novel, orally available, next-generation, small molecule drug candidate designed to positively modulate the neurotrophic HGF system.
About VS Versus Systems Inc.
Versus Systems Inc offers a suite of proprietary business-to-business software tools that are meant to drive user engagement through gamification and rewards. These tools allow its partners to offer in-game prizes and rewards, including merchandise, coupons, digital goods, and sweepstakes entries - inside their websites, their venues, or their streaming media content. Its customers are mostly sports teams, venues, and advertising agencies, which typically use its products as part of their live events or as part of an advertising campaign with the goal of engaging fans, increasing consented first-party data, and increasing sales. The company operates in Canada and the USA.